Methylation of LAPTM4B Promoter Region Influences Its mRNA Expression in Esophageal Cancer

CHENG Xiao-Jing,ZHANG Qing-Yun,ZHOU Rou-Li

DOI: https://doi.org/10.3969/j.issn.1007-7626.2008.01.015

2008-01-01

Abstract:Methylation at the promoter regions is known as one of the key mechanisms to regulate gene transcriptions and greatly concerned in cancer epigenetic studies.By comparing esophageal cancer retrieved from surgical operation to the surrounding normal tissue samples,this study was aimed to identify the methylation sites in the LAPTM4B (lysosome associated protein transmembrane 4 beta) promoter region and determine their methylation status,then evaluate their influences to subsequent LAPTM4B mRNA expression.Three normal/cancer pairing samples were subjected for sequencing and methylation analysis at the promoter region,which utilized pretreatments with sodium disulfide of genome DNAs to protect the cytosine from methylium exposure and transformed into uracil,then amplified using consensus primers for the promoter region of the LAPTM4B gene.Three CpG sites within the LAPTM4B promoter region was identified in one particular normal tissue sample at -418,-416 and -398 bp upstream of the transcription initiation site.Significant difference in LAPTM4B mRNA expression were observed fro ma total of 42 tissue samples between esophageal cancer at 88.1% (37/42) and normal tissues at 61.9% (26/42),determined by semi-quantity RT-PCR based on positive identification.We concluded that the degree of methylation at the multiple CpG sites within the LAPTM4B core promoter region significantly affects its mRNA expression level in esophageal cancer tissues.